Efficacy of daily rectal micronized progesterone for prevention of preterm delivery: a randomized clinical trial

References

• Kashanian M, Shirvani S, Sheikhansari N, et al. A comparative study on the efficacy of nifedipine and indomethacin for prevention of preterm birth as monotherapy and combination therapy: a randomized clinical trial. J Matern Fetal Neonatal Med. 2019:1–6. DOI:https://doi.org/10.1080/14767058.2019.1570117
   Google Scholar
• Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2005. Natl Vital Stat Rep. 2007;56(6):1–103.
   PubMedGoogle Scholar
• Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84.
   PubMed Web of Science ®Google Scholar
• Kashanian M, Bahasadri S, Zolali B. Comparison of the efficacy and adverse effects of nifedipine and indomethacin for the treatment of preterm labor. Int J Gynecol Obstet. 2011;113(3):192–195.
   PubMed Web of Science ®Google Scholar
• Kashanian M, Zamen Z, Sheikhansari N. Comparison between nitroglycerin dermal patch and nifedipine for treatment of preterm labor: a randomized clinical trial. J Perinatol. 2014;34(9):683–687.
   PubMed Web of Science ®Google Scholar
• Naik Gaunekar N, Raman P, Bain E, et al. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2013;10(10):CD004071.
   Google Scholar
• Haas DM, Morgan AM, Deans SJ, et al. Ethanol for preventing preterm birth in threatened preterm labor. Cochrane Database Syst Rev. 2015;11(11):CD011445.
   Google Scholar
• Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2013;5:CD000940.
   Google Scholar
• Kuon RJ, Shi SQ, Maul H, et al. Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle. Am J Obstet Gynecol. 2010;202(5):455.e1–455.e9.
   Web of Science ®Google Scholar
• Lucovnik M, Kuon RJ, Chambliss LR, et al. Progestin treatment for the prevention of preterm birth. Acta Obstet Gynecol Scand. 2011;90(10):1057–1069.
   PubMed Web of Science ®Google Scholar
• Weatherborn M, Mesiano S. Rationale for current and future progestin-based therapies to prevent preterm birth. Best Pract Res Clin Obstet Gynaecol. 2018;52:114–125.
   PubMed Web of Science ®Google Scholar
• Dodd JM, Jones L, Flenady V, et al. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev. 2013;7(7):CD004947.
   Google Scholar
• Romero R, Conde-Agudelo A, Da Fonseca E, et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol. 2018;218(2):161–180.
   PubMed Web of Science ®Google Scholar
• Mackenzie R, Walker M, Armson A, et al. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2006;194(5):1234–1242.
   PubMed Web of Science ®Google Scholar
• Rode L, Langhoff-Roos J, Andersson C, et al. Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies. Acta Obstet Gynecol Scand. 2009;88(11):1180–1189.
   PubMed Web of Science ®Google Scholar
• Kamat S, Veena P, Rani R. Comparison of nifedipine and progesterone for maintenance tocolysis after arrested preterm labour. J Obstet Gynaecol. 2014;34(4):322–325.
   PubMedGoogle Scholar
• Wood S, Rabi Y, Tang S, et al. Progesterone in women with arrested premature labor, a report of a randomised clinical trial and updated meta-analysis. BMC Preg Childbirth. 2017;17(1):258.
   PubMedGoogle Scholar
• Bomba-Opon DA, Kosinska-Kaczynska K, Kosinski P, et al. Vaginal progesterone after tocolytic therapy in threatened preterm labor. J Matern Fetal Neonatal Med. 2012;25(7):1156–1159.
   PubMed Web of Science ®Google Scholar
• Noblot G, Audra P, Dargent D, et al. The use of micronized progesterone in the treatment of menace of preterm delivery. Eur J Obstet Gynecol Reprod Biol. 1991;40(3):203–209.
   PubMed Web of Science ®Google Scholar
• Erny R, Pigne A, Prouvost C, et al. The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol. 1986;154(3):525–529.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Bagga R, Girish B, et al. Effect of maintenance tocolysis with nifedipine in established preterm labour on pregnancy prolongation and neonatal outcome. J Obstet Gynaecol. 2018;38(2):177–184.
   PubMedGoogle Scholar
• Glassman W, Bryam-Smith M, Garfield RE. Changes in rat cervical collagen during gestation and after antiprogesterone treatment as measured in vivo with light-induced autofluorescence. Am J Obstet Gynecol. 1995;173(5):1550–1556.
   PubMed Web of Science ®Google Scholar
• DeFranco EA, O’Brien JM, Adair CD. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007;30(5):697–705.
   PubMed Web of Science ®Google Scholar
• Lucovnik M, Trojner Bregar A, Bombac L, et al. Effects of vaginal progesterone for maintenance tocolysis on uterine electrical activity. J Obstet Gynaecol Res. 2018;44(3):408–416.
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Vergani P, Di Tommaso M, et al. Progestogens for maintenance tocolysis in women with a short cervix: a randomized controlled trial. Obstet Gynecol. 2017;130(1):64–70.
   PubMed Web of Science ®Google Scholar
• Suhag A, Saccone G, Berghella V. Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials. Am J Obstet Gynecol. 2015;213(4):479–487.
   PubMed Web of Science ®Google Scholar
• Ding MX, Luo X, Zhang XM, et al. Progesterone and nifedipine for maintenance tocolysis after arrested preterm labor: a systematic review and meta-analysis of randomized controlled trial. Taiwan J Obstet Gynecol. 2016;55(3):399–404.
   PubMed Web of Science ®Google Scholar
• Palacio M, Ronzoni S, Sánchez-Ramos L, et al. Progestogens as maintenance treatment in arrested preterm labor: a systematic review and meta-analysis. Obstet Gynecol. 2016;128(5):989–1000.
   PubMed Web of Science ®Google Scholar
• Eke AC, Chalaan T, Shukr G, et al. A systematic review and meta-analysis of progestogen use for maintenance tocolysis after preterm labor in women with intact membranes. Int J Gynecol Obstet. 2016;132(1):11–16.
   PubMed Web of Science ®Google Scholar
• Tranguch S, Wang H, Daikoku T, et al. FKBP52 deficiency–conferred uterine progesterone resistance is genetic background and pregnancy stage specific. J Clin Invest. 2007;117(7):1824–1834.
   PubMed Web of Science ®Google Scholar
• Effectiveness of progesterone in reducing preterm births may be altered by genetic predisposition. Available from: https://www.sciencedaily.com/releases/2009/01/090130084153.htm.
   Google Scholar